Workers and families with private health insurance would reap savings on prescription drugs from a little-noticed provision in President Joe Biden's sweeping social agenda bill. Other groups such as the influential U.S. Chamber of Commerce are backing the pharmaceutical industry's drive to block restraints on pricing, including inflation caps, saying.
Polls show that Americans across the political spectrum overwhelmingly favor government action to reduce drug prices. The chief cost complaints are high out-of-pocket costs for patients, high and rising list prices, and high launch prices for new medicines.